Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery

American Journal of Medicine

Volumn 101, Issue 2 A, 1996, Pages 28S-32S

  Faris, Philip ^a  

^a Kendrick Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS SULFATE; HEMOGLOBIN; IRON; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANGINA PECTORIS; BLOOD AUTOTRANSFUSION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; THROMBOSIS; VASCULAR DISEASE; ARTICLE; ORTHOPEDICS; TIME; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; EPOETIN ALFA; HUMANS; ORTHOPEDICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030602927     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)00164-7     Document Type: Conference Paper

References (15)

1. Atabek A, Spence RK, Pello M, Alexander J, Camishion R. Pancreaticoduodenectomy without homologous blood transfusion in an anemic Jehovah's Witness. Arch Surg. 1992;127:349-351.
2. Gaudiani VA, Mason DW. Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures. Ann Thorac Surg. 1991;51:823-824.
3. Rothstein P, Roye D, Verdisco L, Stern L. Preoperative use of erythropoietin in an adolescent Jehovah's Witness. Anesthesiology. 1990;73:568-570.
4. Kyo S, Omoto R, Hirashima K, Eguchi S, Tsuyoshi F. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery: a Japanese multicenter study. Circulation. 1992;86(suppl 2):II-413-II-418.
5. Watanabe Y, Fuse K, Konishi T, et al. Autologous blood transfusion with recombinant human erythropoietin in heart operations. Ann Thorac Surg. 1991;51:767-772.
6. Watanabe Y, Fuse K, Naruse Y, et al. Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg. 1992;54:479-484.
7. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993;341:1227-1232.
8. Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med. 1990;115:28-35.
9. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med. 1989;321:1163-1168.
10. Price TH, Goodnough LT, Vogler WR, et al. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial. Transfusion. 1996;36:29-36.
11. Faris PM, Ritter MA, Abels RI and the American Erythropoietin Study Group. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. J Bone Joint Surg Am. 1996;78-A:62-72.
12. deAndrade JR, Young D, Frei D. Recombinant human erythropoietin (Epoetin alfa) reduces allogeneic transfusions in subjects undergoing orthopaedic surgery. Presented at the 1996 Annual Meeting of the American Academy of Orthopaedic Surgeons, February 22-26, 1996, Atlanta, Georgia. Abstract.
13. deAndrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop. 1996;25:533-542.
14. Goldberg MA, McCutchen JW, Jove M, et al. A safety and efficacy comparison study of two dosing regimens of Epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop. 1996;25:544-556.
15. Rutherford CJ, Schneider TJ, Dempsey H, Kirn DH, Brugnara C, Goldberg MA. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med. 1994;96:139-145.